BERLIN--(BUSINESS WIRE)--BIOTRONIK today announced the publication of the COMPAS clinical trial results in the European Heart Journal1. COMPAS is the first large-scale, prospective, multi-center, randomized clinical trial to demonstrate the safety and efficacy of remote monitoring with BIOTRONIK Home Monitoring® in pacemaker patients. The results further confirm BIOTRONIK Home Monitoring® as the remote monitoring system with the strongest and most robust clinical evidence in the industry.
